These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
182 related articles for article (PubMed ID: 29617836)
1. Met Receptor Tyrosine Kinase and Chemoprevention of Oral Cancer. Saintigny P; William WN; Foy JP; Papadimitrakopoulou V; Lang W; Zhang L; Fan YH; Feng L; Kim ES; El-Naggar AK; Lee JJ; Mao L; Hong WK; Lingen MW; Lippman SM J Natl Cancer Inst; 2018 Mar; 110(3):250-7. PubMed ID: 29617836 [TBL] [Abstract][Full Text] [Related]
2. A novel lncRNA LOLA1 may predict malignant progression and promote migration, invasion, and EMT of oral leukoplakia via the AKT/GSK-3β pathway. Liu W; Yao Y; Shi L; Tang G; Wu L J Cell Biochem; 2021 Oct; 122(10):1302-1312. PubMed ID: 33969929 [TBL] [Abstract][Full Text] [Related]
3. Proliferative activity and loss of function of tumour suppressor genes as 'biomarkers' in diagnosis and prognosis of benign and preneoplastic oral lesions and oral squamous cell carcinoma. Girod SC; Pfeiffer P; Ries J; Pape HD Br J Oral Maxillofac Surg; 1998 Aug; 36(4):252-60. PubMed ID: 9762452 [TBL] [Abstract][Full Text] [Related]
4. Immunohistochemical study of p21 and Bcl-2 in leukoplakia, oral submucous fibrosis and oral squamous cell carcinoma. Sutariya RV; Manjunatha BS J Exp Ther Oncol; 2016 Nov; 11(4):285-292. PubMed ID: 27849339 [TBL] [Abstract][Full Text] [Related]
5. The dynamics of gene expression changes in a mouse model of oral tumorigenesis may help refine prevention and treatment strategies in patients with oral cancer. Foy JP; Tortereau A; Caulin C; Le Texier V; Lavergne E; Thomas E; Chabaud S; Perol D; Lachuer J; Lang W; Hong WK; Goudot P; Lippman SM; Bertolus C; Saintigny P Oncotarget; 2016 Jun; 7(24):35932-35945. PubMed ID: 27027432 [TBL] [Abstract][Full Text] [Related]
6. CD133 expression in oral lichen planus correlated with the risk for progression to oral squamous cell carcinoma. Sun L; Feng J; Ma L; Liu W; Zhou Z Ann Diagn Pathol; 2013 Dec; 17(6):486-9. PubMed ID: 23911820 [TBL] [Abstract][Full Text] [Related]
7. Immunohistochemical location of the p75 neurotrophin receptor (p75NTR) in oral leukoplakia and oral squamous cell carcinoma. Kiyosue T; Kawano S; Matsubara R; Goto Y; Hirano M; Jinno T; Toyoshima T; Kitamura R; Oobu K; Nakamura S Int J Clin Oncol; 2013 Feb; 18(1):154-63. PubMed ID: 22170235 [TBL] [Abstract][Full Text] [Related]
8. Expression of E- Cadherin and Levels of Dysplasia in Oral Leukoplakia - A Prospective Cohort Study. Sathish II; Asokan K; C L K; Ramanathan A Asian Pac J Cancer Prev; 2020 Feb; 21(2):405-410. PubMed ID: 32102518 [TBL] [Abstract][Full Text] [Related]
9. Modulation of the oral glucocorticoid system during black raspberry mediated oral cancer chemoprevention. Nedungadi D; Ryan N; Anderson K; Lamenza FF; Jordanides PP; Swingler MJ; Rakotondraibe L; Riedl KM; Iwenofu H; Oghumu S Carcinogenesis; 2022 Feb; 43(1):28-39. PubMed ID: 34888650 [TBL] [Abstract][Full Text] [Related]
10. Evaluation of cornulin, keratin 4, keratin 13 expression and grade of dysplasia for predicting malignant progression of oral leukoplakia. Schaaij-Visser TB; Bremmer JF; Braakhuis BJ; Heck AJ; Slijper M; van der Waal I; Brakenhoff RH Oral Oncol; 2010 Feb; 46(2):123-7. PubMed ID: 20036603 [TBL] [Abstract][Full Text] [Related]
11. Alteration in the expression of cdk4 and cdk6 proteins in oral cancer and premalignant lesions. Poomsawat S; Buajeeb W; Khovidhunkit SO; Punyasingh J J Oral Pathol Med; 2010 Nov; 39(10):793-9. PubMed ID: 20618617 [TBL] [Abstract][Full Text] [Related]
12. [Histochemical study of lectin receptor and cell morphometric analysis on oral leukoplakias, epithelial dysplasia and squamous carcinoma]. Jiang Y; Wu Y; Wang F Zhonghua Kou Qiang Yi Xue Za Zhi; 1996 Nov; 31(6):351-3. PubMed ID: 9592290 [TBL] [Abstract][Full Text] [Related]
13. [Early detection and prevention of carcinomas of the oral cavity and phraynx]. Matthias C MMW Fortschr Med; 2005 Dec; 147(48):53-5. PubMed ID: 16389863 [TBL] [Abstract][Full Text] [Related]
14. S100A7 overexpression is a predictive marker for high risk of malignant transformation in oral dysplasia. Kaur J; Matta A; Kak I; Srivastava G; Assi J; Leong I; Witterick I; Colgan TJ; Macmillan C; Siu KW; Walfish PG; Ralhan R Int J Cancer; 2014 Mar; 134(6):1379-88. PubMed ID: 24122701 [TBL] [Abstract][Full Text] [Related]
15. The relevance of EGFR overexpression for the prediction of the malignant transformation of oral leukoplakia. Ries J; Vairaktaris E; Agaimy A; Bechtold M; Gorecki P; Neukam FW; Nkenke E Oncol Rep; 2013 Sep; 30(3):1149-56. PubMed ID: 23784518 [TBL] [Abstract][Full Text] [Related]
16. Tivantinib (ARQ-197) exhibits anti-tumor activity with down-regulation of FAK in oral squamous cell carcinoma. Xi WH; Yang LY; Cao ZY; Qian Y Biochem Biophys Res Commun; 2015 Feb; 457(4):723-9. PubMed ID: 25623532 [TBL] [Abstract][Full Text] [Related]
17. STAT3 as a Chemoprevention Target in Carcinogen-Induced Head and Neck Squamous Cell Carcinoma. Peyser ND; Wang L; Zeng Y; Acquafondata M; Freilino M; Li H; Sen M; Gooding WE; Satake M; Wang Z; Johnson DE; Grandis JR Cancer Prev Res (Phila); 2016 Aug; 9(8):657-63. PubMed ID: 27267892 [TBL] [Abstract][Full Text] [Related]
18. PD-1 blockade prevents the progression of oral carcinogenesis. Dong Y; Wang Z; Mao F; Cai L; Dan H; Jiang L; Zeng X; Li T; Zhou Y; Chen Q Carcinogenesis; 2021 Jun; 42(6):891-902. PubMed ID: 33993220 [TBL] [Abstract][Full Text] [Related]